Risk of exposure to blood products during pregnancy: guidance for Zika and other donor deferral policies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works matching IS 00411132 AND DT 2017 AND VI 57 AND IP 3pt2
Results: 19
1
2
A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios.
- Published in:
- 2017
- By:
- Publication type:
- journal article
3
A probable case of West Nile virus transfusion transmission.
- Published in:
- 2017
- By:
- Publication type:
- journal article
4
Amustaline (S-303) treatment inactivates high levels of Zika virus in red blood cell components.
- Published in:
- 2017
- By:
- Publication type:
- journal article
5
Inactivation and removal of Zika virus during manufacture of plasma-derived medicinal products.
- Published in:
- 2017
- By:
- Publication type:
- journal article
6
Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion-transmitted infection in Argentina: high rate of recent infections.
- Published in:
- 2017
- By:
- Publication type:
- journal article
7
Masthead and Table of Contents.
- Published in:
- Transfusion, 2017, v. 57, n. 3pt2, p. n/a, doi. 10.1111/trf.14142
- Publication type:
- Article
8
Cover.
- Published in:
- Transfusion, 2017, v. 57, n. 3pt2, p. C1, doi. 10.1111/trf.14143
- Publication type:
- Article
9
Harmonization of nucleic acid testing for Zika virus: development of the 1<sup>st</sup> World Health Organization International Standard.
- Published in:
- 2017
- By:
- Publication type:
- journal article
10
Zika virus and blood transfusion: the experience of French Polynesia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
11
First Zika-positive donations in the continental United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
12
Inactivation of Zika virus by solvent/detergent treatment of human plasma and other plasma-derived products and pasteurization of human serum albumin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
13
First cases of Zika virus-infected US blood donors outside states with areas of active transmission.
- Published in:
- 2017
- By:
- Publication type:
- journal article
14
Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China.
- Published in:
- 2017
- By:
- Publication type:
- journal article
15
A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
16
The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C virus, and human immunodeficiency virus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
17
Decision making in the face of uncertainty: the challenge of emerging infectious diseases.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
18
Zika virus is not thermostable: very effective virus inactivation during heat treatment (pasteurization) of human serum albumin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
19
Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real-time polymerase chain reaction assays for detection of Zika virus RNA.
- Published in:
- 2017
- By:
- Publication type:
- journal article